EP0396709A4 - Human leukocyte elastase inhibitors and methods of producing and using same - Google Patents

Human leukocyte elastase inhibitors and methods of producing and using same

Info

Publication number
EP0396709A4
EP0396709A4 EP19890912611 EP89912611A EP0396709A4 EP 0396709 A4 EP0396709 A4 EP 0396709A4 EP 19890912611 EP19890912611 EP 19890912611 EP 89912611 A EP89912611 A EP 89912611A EP 0396709 A4 EP0396709 A4 EP 0396709A4
Authority
EP
European Patent Office
Prior art keywords
producing
methods
same
human leukocyte
leukocyte elastase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19890912611
Other languages
English (en)
Other versions
EP0396709A1 (fr
Inventor
George A. Digenis
Bushra J. Agha
Charles Khouri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Kentucky Research Foundation
Original Assignee
University of Kentucky Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/263,385 external-priority patent/US5008245A/en
Priority claimed from US07/409,894 external-priority patent/US5922319A/en
Application filed by University of Kentucky Research Foundation filed Critical University of Kentucky Research Foundation
Publication of EP0396709A1 publication Critical patent/EP0396709A1/fr
Publication of EP0396709A4 publication Critical patent/EP0396709A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP19890912611 1988-10-27 1989-10-27 Human leukocyte elastase inhibitors and methods of producing and using same Withdrawn EP0396709A4 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/263,385 US5008245A (en) 1988-10-27 1988-10-27 Novel peptidyl carbamate inhibitors of the enzyme elastase
US263385 1988-10-27
US409894 1989-09-20
US07/409,894 US5922319A (en) 1989-09-20 1989-09-20 Methods of treating eye conditions with human leukocyte elastase (HLE) inhibitory agents

Publications (2)

Publication Number Publication Date
EP0396709A1 EP0396709A1 (fr) 1990-11-14
EP0396709A4 true EP0396709A4 (en) 1991-05-22

Family

ID=26949819

Family Applications (2)

Application Number Title Priority Date Filing Date
EP19890311130 Pending EP0367514A3 (fr) 1988-10-27 1989-10-27 Inhibiteurs de l'élastase de leukocyte humaine et méthodes pour les produire et leur emploi
EP19890912611 Withdrawn EP0396709A4 (en) 1988-10-27 1989-10-27 Human leukocyte elastase inhibitors and methods of producing and using same

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP19890311130 Pending EP0367514A3 (fr) 1988-10-27 1989-10-27 Inhibiteurs de l'élastase de leukocyte humaine et méthodes pour les produire et leur emploi

Country Status (5)

Country Link
EP (2) EP0367514A3 (fr)
JP (1) JPH03503055A (fr)
AU (1) AU629259B2 (fr)
CA (1) CA2001629A1 (fr)
WO (1) WO1990004409A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI895671A (fi) * 1989-11-27 1991-05-28 Labsystems Oy Skyddande av intraokulaera strukturer.
US5705178A (en) * 1991-05-31 1998-01-06 Gliatech, Inc. Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
US5605938A (en) 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
CZ285911B6 (cs) * 1997-04-30 1999-11-17 Vúfb, A. S. Oligopeptidické inhibitory elastáz
ATE308293T1 (de) * 1998-03-09 2005-11-15 Ista Pharmaceuticals Inc Verwendung von glyceraldehyde als hornhaut härtungsmitteln
WO2001017527A1 (fr) * 1999-09-06 2001-03-15 Ono Pharmaceutical Co., Ltd. Agents destines a la prevention et a au traitement des maladies des yeux
US7678767B2 (en) 2004-06-16 2010-03-16 Pneumrx, Inc. Glue compositions for lung volume reduction
US7468350B2 (en) 2004-06-16 2008-12-23 Pneumrx, Inc. Glue composition for lung volume reduction
WO2006014567A2 (fr) 2004-07-08 2006-02-09 Pneumrx, Inc. Dispositif, procede et materiau pour le traitement d'epanchement pleural

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3481913D1 (de) * 1983-04-27 1990-05-17 Ici America Inc Prolin-derivate.
US4636492A (en) * 1984-08-29 1987-01-13 E. I. Du Pont De Nemours And Company Inhibition of viral protease activity by peptide halomethyl ketones
US4760130A (en) * 1984-12-06 1988-07-26 Synergen Biologicals, Inc. Serine protease inhibitors and methods for isolation of same
US4643991A (en) * 1984-12-18 1987-02-17 The University Of Kentucky Research Foundation Peptide elastase inhibitors and methods

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9004409A1 *

Also Published As

Publication number Publication date
AU629259B2 (en) 1992-10-01
AU4511089A (en) 1990-05-14
EP0367514A2 (fr) 1990-05-09
WO1990004409A1 (fr) 1990-05-03
CA2001629A1 (fr) 1990-04-27
JPH03503055A (ja) 1991-07-11
EP0367514A3 (fr) 1991-05-22
EP0396709A1 (fr) 1990-11-14

Similar Documents

Publication Publication Date Title
GB2215267B (en) Disposable faceshield and method of manufacture thereof
EP0522584A3 (en) Disposable panty and method of producing the same
AU4030089A (en) Artificial heart structure and methods of use
GR900300100T1 (en) Spin-bonded all plastic can and method of forming same
PL278545A1 (en) Method of obtaining novel derivatives of cyclobutylpurine and cyclobutylpyrimidine
IL89885A0 (en) Fibrin-collagen tissue equivalents and their production
AU3678489A (en) Alloy and methods of use thereof
GB2221396B (en) Catheters and methods of manufacture
EG18822A (en) Production and use of prophyrins
EP0423513A3 (en) Laserwafer and method of producing same
EP0396709A4 (en) Human leukocyte elastase inhibitors and methods of producing and using same
ZA899778B (en) Reduction of piperidine-dion-derivatives and intermediates
AU623165B2 (en) Method of inhibiting the spread of disease and infection in structures
NZ227594A (en) Human interleukin-1alpha and preparations thereof
GB8923571D0 (en) Connecting means and method of use thereof
EP0323645A3 (en) Extract of chlorella and use thereof
EP0432619A3 (en) Laminate and method of manufacture
EP0453208A3 (en) Incising tools and methods of their use
GB8927893D0 (en) Silencer and method of producing same
GB9110217D0 (en) Disposable article and method of manufacture
AU631603B2 (en) Detection of human tissue factor activator
EP0459788A3 (en) Modified proteins and methods of producing same
IL90805A0 (en) Catheter and method of using same
ZA911322B (en) Method of identifying human leukocyte types
ZA893970B (en) Methods of construction and implements therefor

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19900711

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19910403

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

XX Miscellaneous

Free format text: VERBUNDEN MIT 89311130.2/0367514 (EUROPAEISCHE ANMELDENUMMER/VEROEFFENTLICHUNGSNUMMER) DURCH ENTSCHEIDUNG VOM 14.05.92.

17Q First examination report despatched

Effective date: 19941028

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19970310